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We describe the molecular basis of cyclic adenosine
monophosphate–stimulated anion secretion in 2-dimensional
human duodenal enteroids and show that active chloride
and bicarbonate secretion occur in both crypt-like–
undifferentiated and villus-like–differentiated enteroids.
BACKGROUND & AIMS: Human enteroids present a novel
tool to study human intestinal ion transport physiology and
pathophysiology. The present study describes the contributions
of Cl- and HCO3
- secretion to total cyclic adenosine mono-
phosphate (cAMP)-stimulated electrogenic anion secretion in
human duodenal enteroid monolayers and the relevant changes
after differentiation.
METHODS: Human duodenal enteroids derived from 4 donors
were grown as monolayers and differentiated by a protocol
that includes the removal of Wnt3A, R-spondin1, and
SB202190 for 5 days. The messenger RNA level and protein
expression of selected ion transporters and carbonic anhy-
drase isoforms were determined by quantitative real-time
polymerase chain reaction and immunoblotting, respectively.
Undifferentiated and differentiated enteroid monolayers
were mounted in the Ussing chamber/voltage-current clamp
apparatus, using solutions that contained as well as lackedCl- and HCO3
-/CO2, to determine the magnitude of forskolin-
induced short-circuit current change and its sensitivity to
speciﬁc inhibitors that target selected ion transporters and
carbonic anhydrase(s).
RESULTS: Differentiation resulted in a signiﬁcant reduction in
the messenger RNA level and protein expression of cystic
ﬁbrosis transmembrane conductance regulator, (CFTR) Naþ/
Kþ/2Cl- co-transporter 1 (NKCC1), and potassium channel,
voltage gated, subfamily E, regulatory subunit 3 (KCNE3); and,
conversely, increase of down-regulated-in-adenoma (DRA),
electrogenic Naþ/HCO3
- co-transporter 1 (NBCe1), carbonic
anhydrase 2 (CA2), and carbonic anhydrase 4 (CA4). Both
undifferentiated and differentiated enteroids showed active
cAMP-stimulated anion secretion that included both Cl- and
HCO3
- secretion as the magnitude of total active anion secretion
was reduced after the removal of extracellular Cl- or HCO3
-/
CO2. The magnitude of total anion secretion in differentiated
enteroids was approximately 33% of that in undifferentiated
enteroids, primarily owing to the reduction in Cl- secretion
with no signiﬁcant change in HCO3
- secretion. Anion secretion
was consistently lower but detectable in differentiated enter-
oids compared with undifferentiated enteroids in the absence
of extracellular Cl- or HCO3
-/CO2. Inhibiting CFTR, NKCC1,
carbonic anhydrase(s), cAMP-activated Kþ channel(s), and
Naþ/Kþ-adenosine triphosphatase reduced cAMP-stimulated
anion secretion in both undifferentiated and differentiated
enteroids.
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physiology of small intestinal epithelium. Enteroid differentia-
tion is associated with signiﬁcant alterations in the expression
of several ion transporters and carbonic anhydrase isoforms,
leading to a reduced but preserved anion secretory phenotype
owing to markedly reduced Cl- secretion but no signiﬁcant
change in HCO3
- secretion. (Cell Mol Gastroenterol Hepatol
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intestinal ion transport is coordinated by intricate regulation
of intracellular and extracellular signals.1 Over the past few
decades, our knowledge of intestinal ion transport has been
revolutionized owing to the application of molecular biology
techniques. To date, the critical transporters mediating the
absorption and secretion of major ions have been identiﬁed
and characterized. Nevertheless, further investigation has
been limited in a number of aspects, in large part because of
the lack of a reliable and complex model system that faith-
fully recapitulates human intestinal ion transport physiology
and pathophysiology. For instance, many observations in
animal models are not reproducible in human subjects,2
which is also an important reason for the failure of many
drug development efforts that begin with great potential in
animal studies but turn out to lack clinical effectiveness and
safety.3 In addition, much of our knowledge of intestinal ion
transport is based on the ﬁndings in nonphysiological
cell models such as transfected nonpolarized cells and
immortalized cancer cell lines. These results should be
interpreted with caution because these models may either
show abnormal behavior in particular aspects as a result of
genetic instability or fail to present the complex coordination
of ion transporters that occurs in the intact human intestine.
To date, the spatial difference in ion transport along the
crypt-villus axis of the small intestine remains not fully un-
derstood. It is widely believed that absorption and secretion
are 2 distinct functions occurring at different sites of the in-
testinal epithelium, with the former occurring in villi and the
latter in crypts. However, a number of studies have suggested
that the 2 transport processes may not be completely
spatially separated along the crypt-villus axis, and reasons
why this separation is unlikely to be so distinct have been
described.1,4–7 In addition, a previous study from our group
showed the expression and function of Naþ/Hþ exchanger 3
(NHE3), which is responsible for the majority of electro-
neutral sodium absorption in the small intestine and a po-
tential drug target for treating diarrhea/constipation,8 in
both crypt-like–undifferentiated enteroids and villus-like-
–differentiated enteroids, suggesting sodium absorption is
not conﬁned to villi.9 Also, several ion transporters that are
thought to contribute to anion secretion, including cystic
ﬁbrosis transmembrane conductance regulator (CFTR), Naþ/
Kþ/2Cl- co-transporter 1 (NKCC1), and electrogenic Naþ/
HCO3
- co-transporter 1 (NBCe1), were detectable byimmunoﬂuorescence in rat villus enterocytes and
co-localized with NHE3.5 CFTR, NBCe1, and, to a lesser extent
NKCC1, also were documented as being expressed in human
villus enterocytes (Turner JR, unpublished data). Moreover, a
chloride-dependent depolarization of apical membrane po-
tential difference was observed upon administration of se-
cretagogues in villi as well as in crypts of rat small intestine.10
Hence, it is reasonable to speculate that anion secretion also
may occur in villi, although the extentmay not be as large as it
is in crypts.1 However, this speculation lacks strong evidence
from human studies, largely owing to the lack of a reliable
method to functionally and physically separate crypt cells
and villus cells of human small intestinal epithelium.
Recently, primary cultures of adult stem cell–derived
intestinal epithelium, called enteroids, have presented a
novel model for studying intestinal health and disease.11–14
Our group has reported the use of 3-dimensional human
enteroids as a tool to study ion transport processes and
has shown a functional similarity between human enteroids
and human small intestine in ion transport physiology
and pathophysiology.9,13 We also conﬁrmed the ability to
differentiate enteroids by removing speciﬁc ingredients
from the culture medium that leads to a separation of
undifferentiated enteroids, which have crypt-like properties,
and differentiated enteroids, which have villus-like proper-
ties, respectively.9,15 This has allowed us to study the spatial
difference in cell biology/physiology along the crypt-villus
axis of the small intestine. Furthermore, our recent devel-
opment of 2-dimensional enteroid monolayer cultures has
greatly expanded our ability to study enteroids using a
variety of approaches, including the Ussing chamber/
voltage-current clamp technique for quantitating active
electrogenic ion transport processes.13,15,16
In this study, we used the model of human duodenal
enteroid monolayers to investigate cyclic adenosine mono-
phosphate (cAMP)-stimulated anion secretion. The aim was
to determine the molecular basis of anion secretion and the
relevant changes upon enteroid differentiation. We herein
report that cAMP-stimulated anion secretion in human
duodenal enteroids is composed primarily of Cl- secretion
with a smaller component of HCO3
- secretion, and is
highly dependent on CFTR, NKCC1, cAMP-activated Kþ
channel(s), Naþ/Kþ–adenosine triphosphatase (ATPase),
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and carbonic anhydrase isoforms are subject to regulation
by differentiation at both the messenger RNA (mRNA) and
protein levels, contributing to a quantitatively reduced but
preserved secretory phenotype of differentiated enteroids.
Materials and Methods
This study was approved by the Institutional Review
Board of Johns Hopkins University School of Medicine
(NA_00038329). All authors had access to the study data
and reviewed and approved the ﬁnal manuscript.
Propagation of Human Enteroid Cultures
The primary cultures of human enteroids were
established using a protocol with minor modiﬁcations from
the method developed by Sato et al,11,17 as previously
described.9 In brief, de-identiﬁed specimens of normal
human small intestine (duodenum/jejunum/ileum) were
obtained during endoscopic or surgical procedures, from
which crypts containing adult stem cells were isolated
to develop enteroids. Enteroids were embedded in Matrigel
(Corning, Tewksbury, MA) in 24-well plates (Corning), and
maintained in expansion medium composed of base medium
of advanced Dulbecco’s modiﬁed Eagle medium/F12 (Life
Technologies, Carlsbad, CA) containing 100 U/mL penicillin/
streptomycin (Quality Biological, Gaithersburg, MD),
10 mmol/L HEPES (Life Technologies), and 1  GlutaMAX
(Life Technologies), with 50% Wnt3A conditioned medium
(produced by L-Wnt3A cell line, ATCC CRL-2647), 15%
R-spondin1–conditioned medium (produced by HEK293T
cell line stably expressing mouse R-spondin1; kindly pro-
vided by Dr Calvin Kuo, Stanford University, Stanford, CA),
10% Noggin conditioned medium (produced by HEK293T
cell line stably expressing mouse Noggin),18 1  B27 sup-
plement (Life Technologies), 1 mmol/L N-acetylcysteine
(Sigma-Aldrich, St. Louis, MO), 50 ng/mL human epidermal
growth factor (Life Technologies), 1 mg/mL (Leu-15) gastrin
(AnaSpec, Fremont, CA), 500 nmol/L A83-01 (Tocris, Bristol,
United Kingdom), 10 mmol/L SB202190 (Sigma-Aldrich), and
100 mg/mL primocin (InvivoGen, San Diego, CA). Enteroids
were cultured in a 5% CO2 atmosphere at 37C and passaged
every 7–12 days. Expansion medium was supplemented with
10 mmol/L Y-27632 (Tocris) and 10 mmol/L CHIR99021
(Tocris) during the ﬁrst 2 days after passaging.
Enteroid Monolayer Formation and Differentiation
Enteroid monolayers were formed as previously
described.15,16 In short, Transwell inserts (polyester
membrane with 0.4-mm pores; Corning) were coated with
10 mg/cm2 human collagen IV solution (Sigma-Aldrich) and
incubated at 37C for at least 2 hours. Enteroids were
harvested, triturated, and added to the top of Transwell
inserts after being resuspended in expansion medium. Each
Transwell insert received approximately 50–100 enteroid
fragments and was maintained with 100 mL expansion
medium on top and 600 mL expansion medium on bottom.
Enteroid monolayers were cultured in a 5% CO2 atmo-
sphere at 37C. Expansion medium was supplemented with
Y-27632 and CHIR99021 during the ﬁrst 2 days afterseeding. Formation of enteroid monolayers was monitored
by morphologic observation using a Zeiss AXIO inverted
microscope (Carl Zeiss, Thornwood, NY) and measurement of
transepithelial electrical resistance (TER). Once monolayers
became conﬂuent, expansion medium was replaced with dif-
ferentiation medium that was made by substituting Wnt3A,
R-spondin1, and SB202190 in the expansion medium with
the base medium. Five days later, paired undifferentiated and
differentiated enteroid monolayers were studied.
Quantitative Real-Time Polymerase
Chain Reaction
Total RNA was extracted using the PureLink RNA Mini Kit
(Life Technologies) according to the manufacturer’s protocol.
Complementary DNA was synthesized from 1 to 2 mg of RNA
using SuperScript VILO Master Mix (Life Technologies).
Quantitative real-time polymerase chain reaction (qRT-PCR)
was performed using Power SYBR Green Master Mix (Life
Technologies) on a QuantStudio 12K Flex real-time PCR sys-
tem (Applied Biosystems, Foster City, CA). Each sample was
run in triplicate, and5ngRNA-equivalent complementaryDNA
was used for each reaction. The sequences of gene-speciﬁc
primers are listed in Table 1. The relative fold changes in
mRNA levels of selected ion transporters and carbonic anhy-
drase isoforms between differentiated enteroids and undif-
ferentiated enteroids (set as 1) were determined using the
2-DDCTmethodwithhuman18S ribosomalRNAsimultaneously
studied and used as the internal control for normalization.
Immunoblotting
Cell pellets were collected from enteroid monolayers and
solubilized in lysis buffer containing 60 mmol/L HEPES, 150
mmol/L NaCl, 3 mmol/L KCl, 5 mmol/L EDTA trisodium,
3 mmol/L ethylene glycol-bis(2-aminoethylether)-N, N, N’,
N’-tetraacetic acid (EGTA), 1 mmol/L Na3PO4, and 1%
Triton X-100 and protease inhibitor cocktail (Sigma-
Aldrich), followed by homogenization by sonication. After
centrifugation at 5000 g for 10 minutes, the supernatant
was collected as the protein lysate. After protein concen-
tration measurement using the bicinchoninic acid method,
protein lysates were mixed with 5 sodium dodecyl sulfate
(SDS) buffer and denatured at 70C for 10 minutes. The
protocol was slightly modiﬁed for the detection of CFTR and
down-regulated-in-adenoma (DRA), in which case protein
lysates were mixed with 5 SDS buffer and incubated at
37C for 10 minutes. Unless otherwise speciﬁed, proteins
were separated by SDS–polyacrylamide gel electrophoresis
on 4%–20% Mini-Protean TGX Precast Gel (Bio-Rad, Her-
cules, CA) and transferred onto nitrocellulose membranes
(Bio-Rad). After blocking with 5% nonfat milk, blots were
probed with primary antibodies overnight at 4C and IRDye-
conjugated secondary antibodies against rabbit and mouse
immunoglobulin G (LI-COR, Lincoln, NE) for 1 hour at room
temperature. Finally, blots were scanned using an Odyssey
CLx imaging system (LI-COR) and the protein bands were
visualized and quantiﬁed using Image Studio software (LI-
COR). The primary antibodies used in this study are listed in
Table 2. Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used as the loading control.
Table 1.Gene-Speciﬁc Primers for qRT-PCR
Gene Forward (50-30) Reverse (50-30)
AE2 TCCCTCTCCTTCCGCAGT TGCTGGTCCAGATCCAAGA
ATP1A1 ACAGACTTGAGCCGGGGATTA TCCATTCAGGAGTAGTGGGAG
ATP1B1 CCGGTGGCAGTTGGTTTAAGA GCATCACTTGGATGGTTCCGA
CA1 TTGAGGACAACGATAACCGATCA CTACGTGAAGCTCGGCAGAAT
CA2 CACCCCTCCTCTTCTGGAAT AGTTTACGGAATTTCAACACCTG
CA4 CTGGTGCTACGAGGTTCAAGC GAAGAAGAAGCGTCCCAGTTT
CA9 CCTTTGCCAGAGTTGACGAG GCAACTGCTCATAGGCACTG
CFTR GAAGTAGTGATGGAGAATGTAACAGC GCTTTCTCAAATAATTCCCCAAA
DRA CCATCATCGTGCTGATTGTC AGCTGCCAGGACGGACTT
GATA4 GGAAGCCCAAGAACCTGAAT GTTGCTGGAGTTGCTGGAA
KCNE3 TTAAGGGAGGTCGTCACTGG ATGCACAAGGCTTCGGTCTA
KCNQ1 GCTTTTCCTAATAAACGTGGAGAA GGAACCAAGGTGAGAGCAGT
Ki67 GAGGTGTGCAGAAAATCCAAA CTGTCCCTATGACTTCTGGTTGT
LGR5 ACCAGACTATGCCTTTGGAAAC TTCCCAGGGAGTGGATTCTAT
NBCe1 CCTCAAGCATGTGTGTGATGA ACTCTTCGGCACATGGACTC
NBCn1 GCAAGAAACATTCTGACCCTCA GCTTCCACCACTTCCATTACCT
NHE1 TCTTCACCGTCTTTGTGCAG ATGGAGCGCTTCGTCTCTT
NHE2 CTTCCACTTCAACCTCCCGAT GCTGCTATTGCCATCTGCAA
NHE3 GTCTTCCTCAGTGGGCTCAT ATGAGGCTGCCAAACAGG
NKCC1 AAAGGAACATTCAAGCACAGC CTAGACACAGCACCTTTTCGTG
PAT-1 TCTACCAGTTCATTGTTCAGAGGA GAGAGGGTAGGTCTTCCAAGG
SI TTTTGGCATCCAGATTCGAC ATCCAGGCAGCCAAGAATC
18S GCAATTATTCCCCATGAACG GGGACTTAATCAACGCAAGC
ATP1A1, Naþ/Kþ–adenosine triphosphatase a-1 subunit; ATP1B1, Naþ/Kþ–adenosine triphosphatase b-1 subunit; KCNE3,
potassium channel, voltage gated, subfamily E, regulatory subunit 3; KCNQ1, potassium channel, voltage gated, subfamily Q,
member 1; LGR5, leucine-rich repeat-containing G-protein–coupled receptor 5; NBCn1, electroneutral Naþ/HCO3
- co-
transporter 1; PAT-1, putative anion transporter 1.
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TER was measured using an EVOM2 epithelial vol-
tohmmeter (World Precision Instruments, Sarasota, FL)
before refreshing the medium. The readings of the vol-
tohmmeter were normalized by the surface area of Trans-
well inserts (0.33 cm2) to calculate the unit area of
resistance (U.cm2).Table 2.Primary Antibodies for Immunoblotting
Antigen Manufacturer
ATP1A1 Developmental Studies Hybridoma Bank (Iowa City, IA)
CA2 Novus (Littleton, CO)
CFTR Cystic Fibrosis Foundation Therapeutics (Chapel Hill, NC
DRA Santa Cruz
GAPDH Sigma-Aldrich
NBCe1 Abcam (Cambridge, MA)
NHE2 Provided by Dr Chung-Ming Tse (Johns Hopkins Univers
NHE3 Novus (Littleton, CO)
NKCC1 Developmental Studies Hybridoma Bank (Iowa City, IA)
ATP1A1, Naþ/Kþ–adenosine triphosphatase a-1 subunit; GAP
applicable.Ussing Chamber/Short-Circuit Current
Measurement
Transwell inserts carrying enteroid monolayers were
mounted in Ussing chambers (Physiological Instruments,
San Diego, CA). The apical and basolateral hemichambers
were ﬁlled with buffer that was gassed continuously
with 95% O2/5% CO2, maintained at 37C, and connectedCatalog number Host Dilution
a5 Mouse 1:1000
NB600-919 Rabbit 1:500
) 217 Mouse 1:400
sc-376187 Mouse 1:200
G8795 Mouse 1:5000
ab30322 Rabbit 1:500
ity, Baltimore, MD) N/A Rabbit 1:500
NBP1-82574 Rabbit 1:500
T4-C Mouse 1:1000
DH, glyceraldehyde-3-phosphate dehydrogenase; N/A, not
Table 3.Compounds for Ussing Chamber/Short-Circuit
Current Measurement
Compound Manufacturer
Final
concentration Side
Acetazolamide Sigma-Aldrich 250 mmol/L AP þ BL
Bumetanide Sigma-Aldrich 100 mmol/L BL
CFTRinh-172 EMD Millipore
(Burlington, MA)
5 or 25 mmol/L AP
Chromanol 293B Sigma-Aldrich 10 mmol/L BL
Forskolin Sigma-Aldrich 10 mmol/L BL
Ouabain Sigma-Aldrich 100 mmol/L BL
S0859 Sigma-Aldrich 30 mmol/L BL
SITS Sigma-Aldrich 1 mmol/L BL
Tenapanor Ardelyx (Fremont, CA) 0.1–1 mmol/L AP
AP, apical; BL, basolateral.
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Instruments) via Ag/AgCl electrodes and 3 mol/L KCl
agar bridges. Krebs–Ringer bicarbonate buffer (KRB buffer)
consisted of 115 mmol/L NaCl, 25 mmol/L NaHCO3,
0.4 mmol/L KH2PO4, 2.4 mmol/L K2HPO4, 1.2 mmol/L CaCl2,
1.2 mmol/L MgCl2, pH 7.4.
19 In Cl--free buffer and HCO3
--free
buffer, Cl- and HCO3
- in KRB buffer were replaced with glu-
conate. Cl--free buffer was supplemented with an additional
5 mmol/L calcium gluconate to maintain the level of free
calcium. HCO3
--free buffer was gassed with 100% O2 and
supplemented with 5 mmol/L HEPES and 1 mmol/L acet-
azolamide to inhibit the endogenous production of HCO3
-/
CO2. In addition, buffer in the basolateral hemichamber was
supplemented with 10 mmol/L glucose as an energy sub-
strate; buffer in the apical hemichamber was supplemented
with 10 mmol/L mannitol to maintain the osmotic balance.
Current clamping was used, and short-circuit current (Isc)
and TER were recorded every 20 seconds by Acquire and
Analyze software (Physiological Instruments). To investigate
the change of short-circuit current (DIsc) in response to an
apical-basolateral gradient of glucose, 40 mmol/L glucose
was added to the apical hemichamber with 40 mmol/L
mannitol to the basolateral hemichamber. To investigate
cAMP-stimulated anion secretion, 10 mmol/L forskolin was
added to the basolateral hemichamber, after which the
effects of inhibitors targeting selected ion transporters
and carbonic anhydrase(s) were studied (Table 3). The time-
course changes in Isc and TER were delineated.
Statistical Analysis
Data are presented as means ± SEM. Statistical analyses
were conducted using the Student’s t test with P < .05
considered statistically signiﬁcant. Studies were performed
using 4 duodenal enteroid lines derived from 4 separate
normal human subjects unless otherwise speciﬁed. In most
cases, experiments were repeated multiple times using
multiple enteroid lines and the results were analyzed
together using a paired t test with statistical analysis
considering the total number of experiments with paired
undifferentiated/differentiated enteroids as the sample size.In several cases, experimental variability within single
enteroid lines was calculated as means ± SEM.
Results
Phenotypic Changes After Differentiation
In previous studies,9,15 we reported a 5-day differentia-
tion protocol of human enteroids that allowed the transition
of undifferentiated enteroids consisting of stem cells, Paneth
cells, and transit-amplifying cells into differentiated enter-
oids made up primarily of enterocytes, goblet cells, and
enteroendocrine cells. In the present study, we further
characterized the phenotypic changes in 2-dimensional
human duodenal enteroids after 5 days of differentiation.
First, there was an increase in TER upon differentiation
(Figure 1A and B); 5-day differentiated enteroid monolayers
had signiﬁcantly higher TER than undifferentiated
enteroid monolayers (1167 ± 140 U.cm2 vs 371 ± 29 U.cm2;
P < .001), but prolonged differentiation up to 7 days did
not cause an additional increase in TER. This is in accordance
with our previous observation in human jejunal enteroid
monolayers.15 Second, differentiated enteroid monolayers
showed a higher response rate to an apical-basolateral
gradient of glucose than undifferentiated enteroid mono-
layers in the magnitude of maximal increase in Isc (15.6 ± 2.9
mA/cm2 vs 7.8 ± 1.5 mA/cm2; P < .001) (Figure 1C and D),
indicating an increase in the apical Naþ-glucose co-transport
activity after differentiation. Third, Sucrase-isomaltase (SI) , a
brush-border glucosidase enzyme and intestinal differentia-
tion marker, was up-regulated signiﬁcantly at the mRNA
level upon differentiation (Figure 1E). Fourth, the mRNA
levels of leucine-rich repeat-containing G-protein–coupled
receptor 5 (LGR5), an intestinal stem cell marker, and Ki67, a
cellular proliferation marker, were dramatically reduced
with differentiation (Figure 1F and G).
In addition, studies were performed to characterize the
segment-speciﬁc identify of duodenal enteroid monolayers
before and after differentiation. GATA4 is an intestinal
segment-speciﬁc transcription factor that controls the
cephalocaudal expression pattern of small intestine by
repressing the expression of ileum-speciﬁc genes in upper
small intestinal segments.20,21 The current study found that
GATA4 mRNA was conﬁned to human enteroid monolayers
derived from duodenum and jejunum, and its amount was
maintained in duodenum and slightly increased in jejunum
after differentiation (Figure 1H). Taken together, these
results present additional evidence that the 5-day differen-
tiation protocol allows the separation of crypt-like cells
(undifferentiated enteroids) and villus-like cells (differenti-
ated enteroids) without affecting their segment-speciﬁc
identity in 2-dimensional human duodenal enteroids,
encouraging the subsequent investigations on the
differentiation-associated modulations of ion transport.
Expression of Ion Transporters and Carbonic
Anhydrase Isoforms Upon Differentiation
To investigate the alterations of ion transport after
differentiation, mRNA levels of selected ion transporters
and carbonic anhydrase isoforms were examined in
Figure 1. Phenotypic changes of human enteroid monolayers upon differentiation. (A) TER of undifferentiated (UD) and
differentiated (DF) duodenal enteroid monolayers over time. Differentiated enteroids had a signiﬁcantly higher TER than un-
differentiated enteroids on day 4 (*P < .05) and day 5 (***P < .001). n ¼ 6 experiments with paired enteroid monolayers derived
from 3 donors. (B) There was no difference in TER between duodenal enteroid monolayers that were differentiated for 5 days or
7 days (1162 ± 246 U.cm2 vs 1042 ± 193 U.cm2, P ¼ .06). *P < .05. n ¼ 3 experiments with paired enteroid monolayers derived
from 3 donors. (C and D) A representative trace and quantitative analysis showing a higher response in DIsc to an apical-
basolateral gradient of glucose (30 mmol/L) in differentiated enteroids than undifferentiated enteroids (***P < .001). n ¼ 4
experiments with paired enteroid monolayers derived from 4 donors. (E–G) qRT-PCR data showing the mRNA level of sucrase-
isomaltase (SI) was increased by 15.4 ± 4.6 times upon differentiation, whereas that of leucine-rich, repeat-containing,
G-protein–coupled receptor 5 (LGR5) and Ki67 was reduced by 379 ± 209 and 102 ± 27 times, respectively. **P < .01, ***P <
.001. n ¼ 4–8 experiments with paired enteroid monolayers derived from 4 donors. (H) qRT-PCR data showing that GATA4
gene expression was conﬁned to duodenal and jejunal enteroid monolayers with no change in duodenum and a slight increase
in jejunum after differentiation. **P < .01. n.d., not detected (threshold [Ct] value >34). n ¼ 3 experiments with paired enteroid
monolayers derived from 3 donors (duodenum, jejunum) or 2 donors (ileum).
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monolayers by qRT-PCR. The ion transporters and carbonic
anhydrase isoforms selected are known to play important
roles in Cl- and HCO3
- secretion, electroneutral Naþ
absorption, and intracellular pH regulation under physiolog-
ical andpathophysiological conditions. As shown in Figure2A,
several ion transporters and carbonic anhydrase isoforms
were up-regulated signiﬁcantly at the mRNA level upon
differentiation. These included carbonic anhydrase (CA)4
(64.4-fold), DRA (21.6-fold), CA2 (4.0-fold), NHE1 (2.7-fold),
NBCe1 (2.4-fold), and Naþ/Kþ–adenosine triphosphatase b-1
subunit (ATP1B1) (1.7-fold). In contrast, several ion trans-
porters were down-regulated signiﬁcantly after differentia-
tion, including NKCC1 (7.1-fold), potassium channel, voltage
gated, subfamily E, regulatory subunit 3 (KCNE3) (5.2-fold),
and CFTR (2.7-fold). The mRNA levels of the following ion
transporters and carbonic anhydrase isoforms were not
signiﬁcantly changed by differentiation: anion exchanger 2
(AE2), Naþ/Kþ–adenosine triphosphatase a-1 subunit
(ATP1A1), CA1, CA9, potassium channel, voltage gated, sub-
family Q, member 1 (KCNQ1), electroneutral Naþ/HCO3
- co-
transporter 1 (NBCe1), NHE2, NHE3, and putative anion
transporter 1 (PAT-1). The qRT-PCR threshold values are
shown in Figure 2B. Most of these ﬁndings in 2-dimensional
enteroids were consistent with the results obtained from
in parallel studies of 3-dimensional enteroids (Figure 3).We further studied the protein expression of selected ion
transporters and carbonic anhydrase isoforms in undiffer-
entiated and differentiated duodenal enteroid monolayers
by immunoblotting (Figure 4A and B). Consistent with the
results of qRT-PCR, CFTR (2.0-fold) and NKCC1 (4.0-fold)
were down-regulated signiﬁcantly at the protein level,
CA2 (2.5-fold), DRA (4.6-fold) and NBCe1 (2.3-fold) were
up-regulated signiﬁcantly, and ATP1A1 and NHE2 were not
changed upon differentiation. Although there was no signif-
icant change at the mRNA level, the protein expression of
NHE3 was slightly but signiﬁcantly up-regulated by 1.5-fold
after differentiation. In sum, these data suggest a signiﬁcant
regulatory effect of differentiation on the expression of
multiple ion transporters and carbonic anhydrase isoforms,
some of which are known to be essential for intestinal Cl- and
HCO3
- secretion.Reduced cAMP-Stimulated Anion Secretion
Upon Differentiation
To study anion secretion at the functional level,
Transwell inserts carrying paired undifferentiated and
differentiated enteroid monolayers were mounted in Ussing
chambers, and forskolin was used to induce cAMP-
stimulated electrogenic anion secretion as indicated by the
increase in short-circuit current. As shown in Figure 5A and D,
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-/CO2 are
both present, forskolin caused an immediate increase in
Isc in both undifferentiated enteroids (34.8 ± 4.6 mA/cm
2)
and differentiated enteroids (10.4 ± 1.3 mA/cm2). Based on
the existing knowledge of cAMP/protein kinase A–induced
anion secretion, we speculated that cAMP-stimulated
anion secretion in KRB buffer consisted of 2 major compo-
nents, namely Cl- secretion and HCO3
- secretion, and that
each component was largely dependent on the presence of
extracellular Cl- and HCO3
-/CO2, respectively. As such, we
investigated whether the removal of extracellular Cl- or
HCO3
-/CO2 reduced cAMP-stimulated secretion. Figure 5B
and C show that duodenal enteroid monolayers had a
smaller response to forskolin in HCO3
--free buffer and
Cl--free buffer. Quantitatively, the magnitude of forskolin-
induced DIsc was 27.7 ± 4.8 mA/cm
2 in HCO3
--free buffer
and 3.3 ± 0.6 mA/cm2 in Cl--free buffer for undifferentiated
enteroids, and was 3.9 ± 0.9 mA/cm2 in HCO3
--free buffer
and 0.5 ± 0.1 mA/cm2 in Cl--free buffer for differentiated
enteroids (Figure 5D). Figure 5E shows the experimental
variability by showing the means ± SEM of the maximal
forskolin response of 4 separate enteroid lines in KRB,
HCO3
--free, and Cl--free buffer. We further normalized the
magnitude of forskolin-induced DIsc in HCO3
--free and Cl--
free buffer to that in KRB buffer (set as 100%). As shown in
Figure 5F, there was a reduction to 80% ± 7% in HCO3
--free
buffer and 9% ± 2% in Cl--free buffer for undifferentiated
enteroids, and 41% ± 8% in HCO3
--free buffer and 5% ± 2%
in Cl--free buffer for differentiated enteroids (these data
were calculated by considering all experiments within a
single enteroid line as n ¼ 1 and are shown as the means ±
SEM of 4 enteroid lines). These results support the specu-
lation that when extracellular Cl- and HCO3
-/CO2 are both
available, the cAMP-stimulated anion secretion from enter-
oid monolayers comprises both Cl- and HCO3
- secretion.
Furthermore, these results indicate a higher dependency of
cAMP-stimulated anion secretion on extracellular Cl- than
on extracellular HCO3
-/CO2.
We also compared undifferentiated and differentiated
enteroids in their response to forskolin in multiple buffers.
In KRB buffer, the maximal increase of Isc in response to
forskolin was signiﬁcantly lower in differentiated enter-
oids, which was 33% ± 4% of that of undifferentiated
enteroids (P < .001) (Figure 5G). This is in contrast to our
previous ﬁnding in 3-dimensional duodenal enteroids that
forskolin-induced swelling was greater in differentiated
than undifferentiated enteroids.9 Notably, we have
changed the nature of expansion medium for enteroids
since the initial report9 and used the modiﬁed expansion
medium which lacks nicotinamide in the current study
(see the Materials and Methods section).22 As shown
in Figure 5J, when studies were repeated using the modi-
ﬁed expansion medium, forskolin-induced swelling
was greater in undifferentiated than differentiated
3-dimensional duodenal enteroids. In the present study,
the magnitude of forskolin-induced DIsc in duodenal
enteroid monolayers was consistently lower in differenti-
ated enteroids compared with undifferentiated enteroids
in multiple buffer conditions: 16% ± 3% of that ofundifferentiated enteroids in HCO3
--free buffer (P < .001)
(Figure 5H) and 15% ± 2% in Cl--free buffer (P < .001)
(Figure 5I). These results show reduced anion secretion
after differentiation; however, forskolin-induced DIsc was
still detectable in differentiated enteroids in all buffer
conditions, suggesting a preserved anion secretory
phenotype in differentiated enteroids.
Apical Ion Transporters in cAMP-Stimulated
Anion Secretion
Anion secretion involves multiple ion transporters that
are located on the apical and basolateral membranes of
intestinal epithelial cells. The contribution of selected ion
transporters to cAMP-stimulated anion secretion was
determined using speciﬁc inhibitors, and the effects of
these inhibitors on TER were studied simultaneously
(Figure 6). CFTR is an apical ion channel that is permeable
to both Cl- and, to a lesser extent, HCO3
-.23 A previous
study showed that blocking CFTR resulted in substantial
inhibition of forskolin-induced DIsc as well as luminal ﬂuid
accumulation in jejunal enteroids.24 In this study, we
further conﬁrmed the role of CFTR in cAMP-stimulated
anion secretion of duodenal enteroid monolayers using
CFTRinh-172 as a CFTR blocker. In KRB buffer, CFTRinh-172
(25 mmol/L) inhibited 85% ± 3% and 95% ± 8% of
forskolin-induced DIsc in undifferentiated and differenti-
ated enteroids, respectively (Figure 7A and D). A lower
dose of CFTRinh-172 (5 mmol/L) also inhibited the majority
of forskolin-induced DIsc in KRB buffer (84% ± 6% for
undifferentiated enteroids and 87% ± 6% for differenti-
ated enteroids) (Figure 7E). Similarly, the inhibitory effect
of CFTRinh-172 (25 mmol/L) of 90%–119% of the
forskolin-induced DIsc was observed in HCO3
--free buffer
and Cl--free buffer (Figure 7B–D).
A previous study by our group reported a potential role
of NHE3 in forskolin-induced swelling in 3-dimensional
duodenal enteroids, but it was not clear whether NHE3
participates in this process through its role in Naþ absorp-
tion, anion secretion, or both.9 To address this, we studied
the effect of tenapanor, a novel NHE3 inhibitor with a me-
dian inhibitory concentration in the nanomolar range,8 on
forskolin-induced DIsc in duodenal enteroid monolayers. As
shown in Figure 7F, the addition of up to 1 mmol/L tena-
panor did not have any signiﬁcant effect on forskolin-
induced DIsc in either undifferentiated or differentiated
enteroids in KRB buffer. Therefore, NHE3 does not appear
to contribute to cAMP-stimulated anion secretion in
duodenal enteroids.
Basolateral Ion Transporters and Carbonic
Anhydrase(s) in cAMP-Stimulated
Anion Secretion
A number of compounds that target selected basolateral
ion transporters and carbonic anhydrase(s) were used to
determine their roles in cAMP-stimulated anion secretion. In
KRB buffer, administration of bumetanide, a speciﬁc blocker
of NKCC1, caused a dramatic reduction in forskolin-induced
DIsc in undifferentiated enteroids and a lesser reduction in
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Figure 3. mRNA level of selected ion transporters and carbonic anhydrase isoforms in 3-dimensional human duodenal
enteroids. The mRNA levels of selected ion transporters and carbonic anhydrase isoforms were determined by qRT-PCR and
the relative fold changes between differentiated (DF) and undifferentiated (UD) 3-dimensional enteroids (set as 1) were
calculated using 18S ribosomal RNA as the endogenous control. These data are mostly consistent with those of parallel
studies in duodenal enteroid monolayers (See results in Figure 2). *P < .05, **P < .01, ***P < .001. n ¼ 5 experiments with
paired 3-dimensional enteroids derived from 5 donors.
Figure 2. (See previous page). mRNA levels of selected ion transporters and carbonic anhydrase isoforms in human
duodenal enteroid monolayers. (A) The mRNA levels of selected ion transporters and carbonic anhydrase isoforms were
determined by qRT-PCR and the relative fold changes between differentiated (DF) and undifferentiated (UD) enteroid
monolayers (set as 1) were calculated using 18S ribosomal RNA as the endogenous control. Most of the results are consistent
with those in parallel studies of 3-dimensional duodenal enteroids (See results in Figure 3). *P < .05, **P < .01, ***P < .001. n ¼
4–8 experiments with paired enteroid monolayers derived from 4 donors. (B) Scatter plots showing the threshold [Ct] values of
selected genes in undifferentiated and differentiated duodenal enteroid monolayers. Each plot represents the result of a single
experiment. A total of 5 ng RNA-equivalent complementary DNA was used for each qRT-PCR reaction. These Ct values
were further normalized to 18S ribosomal RNA (Ct valuew7–8) to determine the relative amount of each gene in each sample.
n ¼ 4–8 experiments with paired enteroid monolayers derived from 4 donors.
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bumetanide-insensitive component was observed, particu-
larly in differentiated enteroids. We then studied whether
this bumetanide-insensitive component could be inhibited
by acetazolamide, a general carbonic anhydrase inhibitor. As
shown in Figure 8A and B, the bumetanide-insensitive
component was sensitive to acetazolamide, and the combi-
nation of bumetanide and acetazolamide abolished
forskolin-induced DIsc regardless of their order of addition.
These results conﬁrm that forskolin-induced DIsc in KRBbuffer is contributed by Cl- secretion and HCO3
- secretion
as 2 major components, and suggest the involvement of
NKCC1 and carbonic anhydrase(s) in cAMP-stimulated
anion secretion through their roles in Cl- secretion and
HCO3
- secretion, respectively.
We further compared undifferentiated and differentiated
enteroids in their sensitivity to bumetanide and acetazol-
amide (Figure 8C and D). The bumetanide-sensitive
component accounted for a relatively greater percentage
in undifferentiated enteroids than differentiated
2018 Anion Secretion In Human Duodenal Enteroids 601enteroids (75% ± 3% vs 44% ± 5%; P < .001), whereas
the acetazolamide-sensitive component contributed to a
relatively larger percentage in differentiated enteroids
than undifferentiated enteroids (51% ± 8% vs 13% ± 2%;
P < .001). We also calculated the absolute reduction
in forskolin-induced DIsc after the addition of acetazolamide
(Figure 8E). This represents the acetazolamide-sensitive
anion secretion and was very similar between undiffer-
entiated enteroids and differentiated enteroids (4.4 ± 0.8
mA/cm2 vs 5.3 ± 0.9 mA/cm2, P ¼ .35).
In addition, we found that cAMP-stimulated anion
secretion in duodenal enteroid monolayers required active
Naþ/Kþ-ATPase because ouabain caused a decrease in
forskolin-induced DIsc with a rapid onset within 2 minutes
of addition (Figure 8F). Moreover, although several
previous publications have suggested a potential role of
basolateral anion exchangers such as AE2 and sodium/
bicarbonate co-transporters such as NBCe1 in anion
secretion, the present study failed to validate the functional
involvement of these transporters in cAMP-stimulated
anion secretion in human duodenal enteroids because
there was no evident inhibition of forskolin-induced
DIsc after the administration of disodium 4-acetamido-
40-isothiocyanato-stilben-2,20-disulfonate (SITS), which in-
hibits AE2, or S0859, which inhibits the NBC family
(Figure 8G and H).25,26Basolateral Ion Transporters in cAMP-Stimulated
Cl- Secretion
We also studied the functional involvement of several
basolateral ion transporters in HCO3
--free buffer, in which
forskolin-induced DIsc was completely attributed to elec-
trogenic Cl- secretion via CFTR. In the absence of HCO3
-/
CO2, inhibition of NKCC1 by bumetanide abolished
forskolin-induced DIsc in both undifferentiated enteroids
(97% ± 3%) and differentiated enteroids (120% ± 10%),
verifying the essential role of NKCC1 as a basolateral Cl-
loader (Figure 9A and B). In addition, the extensive and
rapid-onset inhibitory effect of ouabain also occurred in
HCO3
--free buffer (Figure 9C). Finally, we found that 57% ±
13% and 38% ± 8% of the forskolin-induced DIsc inFigure 4. (See previous page). Protein expression of select
human duodenal enteroid monolayers. (A) Representative im
transporters and carbonic anhydrase isoforms in undifferentiate
derived from 3 donors. Immunoblotting was performed using
immunoblot of DRA shows 2 bands representing 2 glycosy
quantitation (see Figure 4C and D). Note that the nitrocellulose
primary antibodies. Proteins that were blotted with rabbit polyc
with mouse monoclonal antibodies are shown in green. (B)
expression of CA2, DRA, NBCe1, NHE3, and a decrease in C
formed using glyceraldehyde-3-phosphate dehydrogenase (GA
n ¼ 6–13 experiments with paired enteroid monolayers derived
studied by immunoblotting using mouse monoclonal primary an
between wild type HEK cells (lacking DRA mRNA and protein
showed 2 potential DRA bands. A deglycosylation study was
MA) according to the manufacturer’s protocols, showing the
differentiated duodenal enteroid monolayers (endogenous DR
3xFLAG-DRA (exogenous DRA expression).undifferentiated and differentiated enteroids, respectively,
was inhibited by chromanol 293B, indicating the depen-
dence of Cl- secretion on basolateral cAMP-activated Kþ
channel(s) (Figure 9D and E).27Discussion
The present study documents the changes in
cAMP-stimulated anion secretion and expression of relevant
ion transporters during differentiation of normal human
duodenal enteroid monolayers, showing the following:
(1) similarities with the previous characterization of
3-dimensional human duodenal enteroids, although the
changes in expansion medium seem to cause changes in
some aspects of the secretory processes9,22; (2) that cAMP-
stimulated anion secretion occurs in both undifferentiated
and differentiated enteroid monolayers, further supporting
that ion transport processes in human undifferentiated and
differentiated enteroids are more quantitatively than qual-
itatively different9,13; (3) that both undifferentiated and
differentiated enteroids perform what appears to be cAMP-
stimulated Cl- secretion and HCO3
- secretion, with Cl-
secretion being predominant; and (4) that although total
anion secretion is much less in differentiated enteroids, the
extent of HCO3
- secretion is similar in differentiated and
undifferentiated enteroids.
Initially, we showed that the removal of Wnt3A/
R-spondin1/SB202190 induced differentiation in
duodenal enteroid monolayers, as supported by several
phenotypic changes characterized at day 5. Comparison
between undifferentiated and differentiated enteroid
monolayers also showed several differentiation-related
alterations in the expression of multiple ion transporters
and carbonic anhydrase isoforms, consistent with the
results based on studies of intact human (Turner JR,
unpublished data) and animal small intestine.5 These
data support our ability to separately study intestinal
epithelial cells that represent crypts and villi using
undifferentiated and differentiated enteroids. However,
where along the villus our differentiation protocol is
modeling is difﬁcult to state given that not all villus cells
are differentiated to the same extent, presumablyed ion transporters and carbonic anhydrase isoforms in
munoblots showing the protein expression of selected ion
d (UD) and differentiated (DF) duodenal enteroid monolayers
4%–20% gradient gel or 8% gel (for DRA and CFTR). The
lated forms of DRA protein, both of which were used for
membranes were cut into 2 pieces to be blotted with multiple
lonal antibodies are shown in red, proteins that were blotted
Quantitation showing a signiﬁcant increase in the protein
FTR and NKCC1 after differentiation. Calculation was per-
PDH) as the loading control. *P < .05, **P < .01, *** P < .001.
from 3–4 donors. (C and D) Protein expression of DRA was
tibody (sc-376187; Santa Cruz, Dallas, TX). The comparison
) and HEK cells with transient transfection of 3xFLAG-DRA
performed using PNGase F (New England Biolabs, Ipswich,
2 bands represent 2 glycosylated forms of DRA protein in
A expression) and HEK cells with transient transfection of
602 Yin et al Cellular and Molecular Gastroenterology and Hepatology Vol. 5, No. 4continuing to differentiate as they move from the base of
villus to the tip. Moreover, data are lacking that show
the differentiation state and expression of transport
proteins in epithelial cells at multiple positions along
the human intestinal villus. Similarly, although the crypt
base has LGR5-positive stem cells, Paneth cells, and
transit-amplifying cells that proliferate, it is likely that
cells of multiple states of differentiation are present,
particularly at the upper crypt. Importantly, it isnot yet known where in the crypt the anion secretory
cells appear.
A major contribution of this study is the identiﬁcation of
the transport processes and cell populations that contribute
to small intestinal anion secretion stimulated by increased
intracellular cAMP. Although the functional relevance of
enteroids to understanding human intestinal ion transport
physiology has been shown by several previous studies,9,24
the characterization of human intestinal anion secretory
2018 Anion Secretion In Human Duodenal Enteroids 603processes remains incomplete. In the present study, we
deﬁned active electrogenic anion secretion stimulated by
forskolin in human duodenal enteroid monolayers by
the Ussing chamber/voltage-current clamp technique.
Speciﬁcally, this includes cAMP-stimulated Cl- secretion
(HCO3
--independent and HCO3
--dependent) and HCO3
-
secretion (Cl--independent and Cl--dependent). It is impor-
tant to point out that only electrogenic ion transport is
deﬁned by the approach of measuring Isc; this did not allow
us to speciﬁcally quantitate the electroneutral Cl--dependent
HCO3
- secretion that is provided by an apical anion
exchanger, such as DRA, which exchanges Cl- that is secreted
by CFTR for intracellular HCO3
-, and that together with
the linked CFTR-related Cl- secretion is an overall electro-
genic process.28 Similarly, the speciﬁc contribution of
HCO3
--dependent Cl- secretion, which includes the putative
activated DRA stimulation of CFTR activity, could not be
determined,29,30 nor is it known if it occurs in intact
mammalian small intestine. In addition, the current study
was not able to simultaneously quantitate the amount of
active HCO3
- transport, given that our available equipment
could not accomplish simultaneous pH titration and short-
circuiting. In addition, although we have found many simi-
larities in cAMP-stimulated secretion between enteroids
derived from duodenum and jejunum, the ﬁndings of the
current study in duodenal enteroids may not be completely
extrapolated to other small intestinal segments given the
special functions of each segment.
cAMP-stimulated anion secretion was present in both
the crypt-like–undifferentiated enteroids and the villus-
like–differentiated enteroids with the following character-
istics. First, the magnitude of forskolin-stimulated anion
secretion in differentiated enteroids was approximately
33% of that in undifferentiated enteroids. Second, a reduc-
tion in the magnitude of forskolin-induced DIsc wasFigure 5. (See previous page). cAMP-stimulated electrogenic
(A–C) Representative traces showing forskolin-induced DIsc arisi
enteroid monolayers in (A) KRB buffer, (B) HCO3
--free buffer, an
was added to the basolateral side to induce anion secretion. (D)
for undifferentiated enteroids and differentiated enteroids in m
single experiment (n ¼ 1–3 enteroid monolayers). Statistical an
n ¼ 11–19 experiments with paired enteroid monolayers derived
each enteroid line from Figure 4D. Each plot represents the resu
color represents a single enteroid line derived from an individu
forskolin-induced DIsc between enteroid lines derived from di
enteroid line. The horizontal lines are the means, and the stand
single enteroid line. n ¼ 11–19 experiments with paired enteroid
comparing the magnitude of forskolin-induced DIsc in HCO3
--f
100%). In both undifferentiated and differentiated enteroids, ther
removal of extracellular HCO3
-/CO2 and an even more pronoun
**P < .01, ***P < .001. n ¼ 4 enteroid lines derived from 4 sepa
enteroid line and the averages of each enteroid line subsequent
number of enteroid lines as the sample size). (G–I) Quantitation
DIsc in differentiated enteroids compared with undifferentiated en
and (I) Cl--free buffer. ***P < .001. n ¼ 11–19 experiments with
buffer condition. (J) Representative time-course changes of for
derived from 2 donors. Forskolin-induced swelling assay was
previous ﬁnding, the current study found greater forskolin-indu
enteroids, which likely resulted from the changes in the compo
being the removal of nicotanamide.22observed in both undifferentiated and differentiated enter-
oids after the removal of extracellular Cl-, presumably owing
to loss of Cl- secretion and also Cl--dependent HCO3
- secre-
tion. Similarly, the removal of extracellular HCO3
-/CO2,
which causes loss of HCO3
- secretion and HCO3
--dependent
Cl- secretion, resulted in reduced magnitude of forskolin-
induced DIsc, but this was modest compared with that
with extracellular Cl- removal. Similar effects of extracellular
anion removal also were found in mouse duodenum.31,32
Although the cAMP-stimulated anion secretion in the
absence of extracellular Cl- or HCO3
-/CO2 does not represent
the entire HCO3
- or Cl- secretion, this method of extracellular
anion removal at least allowed us to conﬁrm the de-
pendency of cAMP-stimulated anion secretion on extracel-
lular anions. Third, Cl- secretion, primarily deﬁned as the
bumetanide-sensitive component of forskolin-induced DIsc,
makes up the bulk of anion secretion in undifferentiated
enteroids and a signiﬁcant part in differentiated enteroids.
Speciﬁcally, 75% of the forskolin-induced DIsc was inhibited
by bumetanide in undifferentiated enteroids and 44% in
differentiated enteroids. This is consistent with the in vivo
observation that bumetanide inhibited a large part of
forskolin-induced DIsc without affecting bicarbonate secre-
tion in mouse duodenum.33 Fourth, a bumetanide-
insensitive component of forskolin-induced DIsc was
observed in both undifferentiated and differentiated enter-
oids. This residual component is either Cl- secretion
dependent on another bumetanide-insensitive basolateral
Cl- uptake pathway or HCO3
- secretion. The former has not
been identiﬁed in the small intestine. Also, although the
basolateral anion exchanger AE2, which is present similarly
in undifferentiated and differentiated enteroids, could pro-
vide such a transport pathway,25,33 the lack of effect on
forskolin-induced DIsc by blocking AE2 with SITS suggests it
unlikely to be involved. Of note, this bumetanide-insensitiveanion secretion in human duodenal enteroid monolayers.
ng from undifferentiated (UD) and differentiated (DF) duodenal
d (C) Cl--free buffer. In all experiments, forskolin (10 mmol/L)
Scatter plots showing the magnitude of forskolin-induced DIsc
ultiple buffer conditions. Each plot represents the result of a
alysis was performed using an unpaired t test. ***P < .001.
from 4 donors. (E) Scatter plots showing the individual data of
lt of a single experiment (n ¼ 1–3 enteroid monolayers). Each
al donor. Note the moderate variability in the magnitude of
fferent donors and between experiments within each single
ard error bars show the experimental variability within each
monolayers derived from 4 donors. (F) Quantitative analysis
ree buffer and Cl--free buffer with that in KRB buffer (set as
e was a signiﬁcant reduction in forskolin-induced DIsc after the
ced reduction after the removal of extracellular Cl-. *P < .05,
rate donors (the results were ﬁrst analyzed within each single
ly were combined for statistical analysis considering the total
showing a signiﬁcantly lower magnitude of forskolin-induced
teroids (set as 100%) in (G) KRB buffer, (H) HCO3
--free buffer,
paired enteroid monolayers derived from 4 donors for each
skolin-induced swelling in 3-dimensional duodenal enteroids
performed as previously reported,9 and in contrast to our
ced swelling in undifferentiated enteroids than differentiated
sition of expansion medium, with one of the major changes
Figure 6. Effects of selected compounds on TER. Representative traces showing the effects of selective compounds on
TER. TER was recorded at the same time as short-circuit current was studied. (A–C) Corresponds to Figure 7A–C, (D) cor-
responds to Figure 7F, (E and F) corresponds to Figure 8A and B; (G–I) corresponds to Figure 8F–H, (J) corresponds to
Figure 9A, and (K and L) corresponds to Figure 9C and D.
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Figure 7. Functional involvement of apical ion transporters in cAMP-stimulated electrogenic anion secretion. (A–C)
Representative traces showing the inhibitory effect of CFTRinh-172 (25 mmol/L on the apical side) on forskolin-induced DIsc
arising from undifferentiated (UD) and differentiated (DF) enteroid monolayers in (A) KRB buffer, (B) HCO3
--free buffer, and (C)
Cl--free buffer. (D) Quantitation showing CFTRinh-172 (25 mmol/L on the apical side) inhibited the majority of forskolin-induced
DIsc in both undifferentiated and differentiated enteroids in all buffer conditions. n ¼ 3–5 experiments with paired enteroid
monolayers derived from 2–3 donors for each buffer condition. (E) Quantitation showing a lower dose of CFTRinh-172 (5 mmol/L
on the apical side) also inhibited the majority of forskolin-induced DIsc in both undifferentiated and differentiated enteroids in
KRB buffer. n ¼ 3 experiments with paired enteroid monolayers derived from 2 donors. (F) A representative trace showing the
insensitivity of forskolin-induced DIsc to tenapanor in KRB buffer. The cumulative concentration of tenapanor on the apical side
after each addition was 0.1 mmol/L, 0.5 mmol/L, and 1 mmol/L. This experiment was repeated at least 3 times using paired
enteroid monolayers derived from 2 donors, and similar results were found in each experiment.
2018 Anion Secretion In Human Duodenal Enteroids 605component was seen only in KRB buffer that contains
HCO3
-/CO2; it was not observed in HCO3
--free buffer, sug-
gesting that it involves HCO3
- secretion. In fact, a similar
bumetanide-insensitive component also was found in mouse
duodenum only when extracellular HCO3
- was present.31
That this was likely to be HCO3
- secretion was supported
further by its sensitivity to acetazolamide, which has been
shown to inhibit basal and stimulated HCO3
- secretion in
intact human/animal duodenum.34–36 Taken together, these
results show the similarity of human duodenal enteroid
monolayers and intact human/mouse duodenum in many
aspects of cAMP-stimulated Cl- and HCO3
- secretion.
As we proposed previously,13 that forskolin-induced DIsc
is detectable in villus-like–differentiated enteroids suggests
anion secretion is not strictly conﬁned to crypts, although
a signiﬁcant quantitative difference exists betweendifferentiated and undifferentiated enteroids. The lesser
anion secretion in differentiated enteroids seems to be
caused largely by the reduction in Cl- secretion, which is
related to the reduced expression of CFTR, NKCC1 and
KCNE3, all of which are known to be necessary for cAMP-
stimulated Cl- secretion. Interestingly, several ion trans-
porters and carbonic anhydrase isoforms that are involved
in HCO3
- secretion, including DRA, NBCe1, CA2, and CA4,
were increased in differentiated enteroids. These changes
may explain that the absolute amount of forskolin-induced
DIsc that was inhibited by acetazolamide, which represents
a component of HCO3
- secretion, was similar between un-
differentiated and differentiated enteroids despite a signif-
icant reduction in CFTR expression in the latter. Further
studies are needed to determine whether these changes in
expression lead to increased DRA-related Cl--dependent
Figure 8. Functional involvement of basolateral ion transporters and carbonic anhydrase(s) in cAMP-stimulated
electrogenic anion secretion. (A and B) Representative traces showing forskolin-induced DIsc arising from undifferenti-
ated (UD) and differentiated (DF) enteroid monolayers was sensitive to bumetanide (100 mmol/L on the basolateral side) and
acetazolamide (250 mmol/L on both apical and basolateral sides) in KRB buffer. The combination of the 2 compounds
abolished forskolin-induced DIsc despite their order. (C and D) Quantitation showing the percentage of forskolin-induced
DIsc that was inhibited by (C) bumetanide and (D) acetazolamide in KRB buffer. Undifferentiated enteroids showed a
relatively higher sensitivity to bumetanide than to acetazolamide, whereas differentiated enteroids showed a relatively
higher sensitivity to acetazolamide than to bumetanide. The differences between undifferentiated and differentiated
enteroids in their sensitivity to bumetanide and acetazolamide were statistically signiﬁcant (***P < .001). n ¼ 15 experiments
with paired enteroid monolayers derived from 4 donors. (E) Quantitation showing the absolute reduction in the magnitude of
forskolin-induced DIsc by acetazolamide in KRB buffer. There was no statistical difference between undifferentiated
enteroids and differentiated enteroids. n ¼ 15 experiments with paired enteroid monolayers derived from 4 donors. (F and G)
Representative traces showing the effects of ouabain (F, 100 mmol/L on the basolateral side), SITS (G, 1 mmol/L on the
basolateral side), and S0859 (H, 30 mmol/L on the basolateral side) on forskolin-induced DIsc in KRB buffer. These
experiments were repeated at least 3 times using paired enteroid monolayers derived from 2 to 3 donors, and similar
results were found in each experiment.
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- secretion in differentiated enteroids, a process that
was not determined by the Ussing chamber/voltage-current
clamp technique used in this study.
The present study allowed further dissection of the
contribution of speciﬁc transporters to cAMP-stimulated
anion secretion in duodenal enteroids. On the apical
surface, CFTR was found to be necessary for both Cl- and
HCO3
- secretion because CFTRinh-172 abolished the entire
forskolin-induced DIsc in the presence and absence of
extracellular Cl- and HCO3
-/CO2 in differentiated as well as
undifferentiated enteroids. Thus, CFTR is the major
apical transporter for all duodenal cAMP-stimulated
anion secretion and no other Cl- channel seems to
contribute signiﬁcantly, unless that contribution is indirect
and involves CFTR. Similarly, there appears no role for
NHE3 in cAMP-stimulated anion secretion because
forskolin-induced DIsc was not altered by tenapanor.
However, NHE3 still could have a role in electroneutral
HCO3
- secretion,28,31 which could not be quantitated in
the current study. Any speciﬁc role for DRA and PAT-1
could not be evaluated in this study, although they arelikely to contribute to cAMP-stimulated anion secretion
through their interaction with CFTR.28,37
In terms of the basolateral transporters participating in
cAMP-stimulated Cl- secretion, our results conﬁrmed
NKCC1 as the essential basolateral Cl- loader and the
necessary contributions of cAMP-activated Kþ channel(s)
and Naþ/Kþ-ATPase.32,38,39 As for cAMP-stimulated HCO3
-
secretion, there are 2 potential pathways that could
supply HCO3
- for apical extrusion. One is a Naþ/HCO3
-
co-transporter that interacts with NHE1 to mediate HCO3
-
uptake across the basolateral membrane.36 Our study did
not provide any evidence for the involvement of
NBCs because a speciﬁc inhibitor of the NBC family
(S0859) had no signiﬁcant inhibitory effect but rather a
small stimulatory effect on forskolin-induced DIsc.
A similar transient stimulatory effect of S0859 on
forskolin-induced DIsc also was seen in bronchial epithelial
cells, which could be inhibited by calcium-activated chlo-
ride channel (CaCC) inhibitor.40 The second source of
HCO3
- is the production of intracellular HCO3
- by carbonic
anhydrase(s), the contribution of which is supported by
Figure 9. Functional involvement of basolateral transporters in cAMP-stimulated electrogenic Cl- secretion. (A and B)
A representative trace and quantitative analysis showing the inhibitory effect of bumetanide (100 mmol/L on the
basolateral side) on forskolin-induced DIsc arising from undifferentiated (UD) and differentiated (DF) enteroid monolayers in
HCO3
--free buffer. n ¼ 4 experiments with paired enteroid monolayers derived from 3 donors. (C) A representative trace
showing the inhibitory effect of ouabain (100 mmol/L on the basolateral side) on forskolin-induced DIsc in HCO3
--free buffer.
This experiment was repeated at least 3 times using paired enteroid monolayers derived from 2 donors, and similar results
were found in each experiment. (D and E) A representative trace and quantitative analysis showing the inhibitory effect of
chromanol 293B (10 mmol/L on the basolateral side) on forskolin-induced DIsc in HCO3
--free buffer. n ¼ 5 experiments with
paired enteroid monolayers derived from 2 donors.
2018 Anion Secretion In Human Duodenal Enteroids 607the inhibitory effect of acetazolamide on HCO3
- secretion,
as shown by multiple studies.34–36 In the current study, an
acetazolamide-sensitive component was present in cAMP-
stimulated anion secretion, indicating the requirement
for carbonic anhydrase(s) in HCO3
- secretion. However,
the speciﬁc carbonic anhydrase isoform was not identi-
ﬁed. Two isoforms were up-regulated signiﬁcantly with
differentiation in duodenal enteroids; CA2 is thought to be
the major enzyme involved in intracellular HCO3
- pro-
duction, and CA4 is expressed only in differentiated
enteroids and is reported to interact with CFTR and
facilitate CO2 inﬂux.
41,42
In conclusion, this study describes some of the
molecular basis of cAMP-stimulated anion secretion in
normal human duodenal enteroid monolayers and com-
pares the ion transport processes taking part in anion
secretion in crypt-like–undifferentiated enteroids and
villus-like–differentiated enteroids. We suggest that
human enteroid monolayers are a useful tool to study
multiple physiological and pathophysiological models of
intestinal anion secretion, including the chloride and bi-
carbonate components, as well as those that are causedseparately by crypt-like and villus-like epithelial cells of
human small intestine.References
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